Combination of the PAM4 and CA19-9 biomarkers to improve the detection of pancreatic adenocarcinoma.

被引：0
|
作者：
Gold, David V.
Gaedcke, Jochen
Ghadimi, B. Michael
Goggins, Michael
Hruban, Ralph H.
Liu, Mengling
Newsome, Guy
Goldenberg, David M.
机构：
[1] Ctr Mol Med & Immunol, Garden State Canc Ctr, Morris Plains, NJ USA
[2] Univ Goettingen, Univ Med Ctr, Gottingen, Germany
[3] Johns Hopkins Med Inst, Baltimore, MD USA
[4] New York Univ, Med Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.164
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
164
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma
    Gold, David V.
    Gaedcke, Jochen
    Ghadimi, B. Michael
    Goggins, Michael
    Hruban, Ralph H.
    Liu, Mengling
    Newsome, Guy
    Goldenberg, David M.
    CANCER, 2013, 119 (03) : 522 - 528
  • [2] A decrease in preoperative to postoperative CA19-9 level is a significant predictor of survival in patients with pancreatic adenocarcinoma.
    Ferrone, CR
    Thayer, SP
    Finkelstein, DM
    Muzikansky, A
    Mino-Kenudson, M
    Lauwers, G
    Warshaw, AL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 316S - 316S
  • [3] Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer
    Liu, Jianqiang
    Gao, Jun
    Du, Yiqi
    Li, Zhaoshen
    Ren, Yan
    Gu, Junjun
    Wang, Xiaowei
    Gong, Yanfang
    Wang, Weiwei
    Kong, Xiangyu
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (03) : 683 - 691
  • [4] Prognostic value of CA19-9 in pancreatic adenocarcinoma undergoing pancreaticoduodenectomy
    Tomlinson, JS
    Yeh, JJ
    Coit, DG
    Brennan, MF
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S81 - S81
  • [5] Elevated preoperative levels of CA19-9 and CA125 predicts overall survival time in the pancreatic adenocarcinoma. Single institution series
    Hogendorf, Piotr
    Skulimowski, Aleksander
    Durczynski, Adam
    Kumor, Anna
    Poznanska, Grazyna
    Poznanska, Agnieszka
    Olesna, Aleksandra
    Rut, Joanna
    Juliebo, Siri Overeng
    Szmiel, Aneta
    Strzelczyk, Janusz
    POLISH JOURNAL OF SURGERY, 2020, 92 (03) : 32 - 38
  • [6] Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
    Kim, Jungsun
    Bamlet, William R.
    Oberg, Ann L.
    Chaffee, Kari G.
    Donahue, Greg
    Cao, Xing-Jun
    Chari, Suresh
    Garcia, Benjamin A.
    Petersen, Gloria M.
    Zaret, Kenneth S.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (398)
  • [7] Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma
    Shultz, David B.
    Chan, Cato
    Shaffer, Jenny L.
    Kunz, Pamela L.
    Koong, Albert C.
    Chang, Daniel T.
    PANCREAS, 2014, 43 (05) : 777 - 783
  • [8] Prognostic value of CA19-9 in patients with pancreatic adenocarcinoma after chemoradiotherapy
    Nampei, Y.
    Toyomasu, Y.
    Ochiai, S.
    Mase, T.
    Watanabe, Y.
    Kawamura, T.
    Takada, A.
    Yamashita, Y.
    Li, N.
    Sakuma, H.
    Nomoto, Y.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S568 - S569
  • [9] Differential expression of CD175 and CA19-9 in pancreatic adenocarcinoma
    Cheng, Jane J.
    Matsumoto, Yasuyuki
    Dombek, Gabrielle E.
    Stackhouse, Kathryn A.
    Ore, Ana Sofia
    Glickman, Jonathan N.
    Heimburg-Molinaro, Jamie
    Cummings, Richard D.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [10] Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9
    Tang, Huiyuan
    Partyka, Katie
    Hsueh, Peter
    Sinha, Jessica Y.
    Kletter, Doron
    Zeh, Herbert
    Huang, Ying
    Brand, Randall E.
    Haab, Brian B.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2016, 2 (02): : 210 - +
12345